Evidence map›Paper›PMID 40914936›Full record

ArticleThe Journal of frailty & aging2025

The prevalence of sarcopenia and sarcopenic obesity in a German geriatric day clinic.

Basel Habboub, Emmanuel Oludowole, Robert Speer, Johanna Masuch, Ursula Berger, Markus Gosch, Katrin Singler

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of frailty & aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Basel HabboubDepartment of Geriatrics, Paracelsus Medical University Nuremberg, General Hospital Nuremberg, Nuremberg, Germany. Electronic address: basel.habboub@klinikum-nuernberg.de.
Emmanuel OludowoleInstitute of Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany; Pettenkofer School of Public Health, Munich, Germany.
Robert SpeerDepartment of Geriatrics, Paracelsus Medical University Nuremberg, General Hospital Nuremberg, Nuremberg, Germany.
Johanna MasuchDepartment of Geriatrics, Paracelsus Medical University Nuremberg, General Hospital Nuremberg, Nuremberg, Germany.
Ursula BergerInstitute of Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany; Pettenkofer School of Public Health, Munich, Germany.
Markus GoschDepartment of Geriatrics, Paracelsus Medical University Nuremberg, General Hospital Nuremberg, Nuremberg, Germany.
Katrin SinglerDepartment of Geriatric Medicine, Klinikum Fürth, Fürth, Germany; Institute for Biomedicine of Ageing, Friedrich-Alexander-University, Erlangen-Nürnberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSarcopenia and sarcopenic obesity are defined by the loss of muscle strength and mass. Both diseases pose a growing global challenge. Their prevalences vary between studied populations. The aim of this study is to estimate the prevalences of sarcopenia and sarcopenic obesity in sample of community-dwelling older adults attending a geriatric day clinic.

methodsA secondary analysis of the Paint-II Data (single-center randomized controlled trial on the effects of art therapy) was used to estimate the prevalence of sarcopenia and sarcopenic obesity. Furthermore, a machine learning model predicted factors associated with both diseases.

resultsWe had body composition information on 255 of the 409 Paint-II participants. Their mean age was 81 ± 5 years and 78 % were female. Depending on the appendicular skeletal muscle mass (ASM) definition, the prevalence of sarcopenia ranged between 10 % and 24 % using ASM/height

conclusionsThe prevalence of sarcopenia and sarcopenic obesity among community-dwelling older adults attending geriatric day clinics is higher than among the general geriatric population. There is a significant discrepancy in sarcopenia prevalence depending on whether muscle mass is measured absolutely or adjusted for body size. Diagnosis is further complicated by varying recommended cut-offs. We support efforts to simplify and standardize the diagnostic criteria.

Indexed as

ObesitySarcopeniaAgedAged, 80 and overBody CompositionDay Care, MedicalFemaleGeriatric AssessmentGermanyHumansIndependent LivingMaleMuscle, SkeletalPrevalenceCommunity-dwellingDisease burdenSarcopeniaSarcopenic obesity

Identifiers

PMID40914936
PMCPMC12446630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.